TrialJournal of the American Society of Nephrology : JASN2021

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Pablo E Pergola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.